DavidF.MooreMD

PubMed

• 89 citations
  Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
  Babak Kateb, Katherine Chiu, Keith L. Black, Vicky Yamamoto, Bhavraj Khalsa, Julia Y. Ljubimova, Hui Ding, Rameshwar Patil, Jose Portilla-Arias, Mike Modo, David F. Mo...> ;Neuroimage. 2011 Jan 1
• Stroke surveillance in Manitoba, Canada: estimates from administrative databases.
  Moore, D. F.,Lix, L. M.,Yogendran, M. S.,Martens, P.,Tamayo, A.> ;Chronic Dis Can. 2008 Nov 28
• Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
  Moore, D. F., Pazdur, R., Abbruzzese, J. L., Ajani, J. A., Dubovsky, D. W., Wade, J. L., Belt, R. J., Mangold, C., Bready, B., Winn, R. J.> ;Ann Oncol. 1994 Mar
• Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinoma.
  Moore, D. F., Pazdur, R., Sugarman, S., Jones, D., Lippman, S. M., Bready, B., Abbruzzese, J. L.> ;Am J Clin Oncol. 1995 Dec
• High-strain-rate brain injury model using submerged acute rat brain tissue slices.
  Sarntinoranont, M., Lee, S. J., Hong, Y., King, M. A., Subhash, G., Kwon, J., Moore, D. F.> ;J Neurotrauma. 2012 Jan 20
• Loading velocity dependent permeability in agarose gel under compression.
  Liu, Q., Subhash, G., Moore, D. F.> ;J Mech Behav Biomed Mater. 2011 Oct
• In silico investigation of intracranial blast mitigation with relevance to military traumatic brain injury.
  Nyein, M. K., Jason, A. M., Yu, L., Pita, C. M., Joannopoulos, J. D., Moore, D. F., Radovitzky, R. A.> ;Proc Natl Acad Sci U S A. 2010 Nov 30
• Blast-induced electromagnetic fields in the brain from bone piezoelectricity.
  Lee, K. Y., Nyein, M. K., Moore, D. F., Joannopoulos, J. D., Socrate, S., Imholt, T., Radovitzky, R., Johnson, S. G.> ;Neuroimage. 2011 Jan
• Military traumatic brain injury and blast.
  Moore, D. F., Jaffee, M. S.> ;NeuroRehabilitation. 2010
• Head injury as a PTSD predictor among Oklahoma City bombing survivors.
  Walilko, T., North, C., Young, L. A., Lux, W. E., Warden, D. L., Jaffee, M. S., Moore, D. F.> ;J Trauma. 2009 Dec
• Case report of a soldier with primary blast brain injury.
  Warden, D. L., French, L. M., Shupenko, L., Fargus, J., Riedy, G., Erickson, M. E., Jaffee, M. S., Moore, D. F.> ;Neuroimage. 2009 Aug 01
• Computational biology - modeling of primary blast effects on the central nervous system.
  Moore, D. F., Jérusalem, A., Nyein, M., Noels, L., Jaffee, M. S., Radovitzky, R. A.> ;Neuroimage. 2009 Aug
• Skin-impedance in Fabry Disease: a prospective, controlled, non-randomized clinical study.
  Gupta, S. N., Ries, M., Murray, G. J., Quirk, J. M., Brady, R. O., Lidicker, J. R., Schiffmann, R., Moore, D. F.> ;BMC Neurol. 2008 Nov 08
• Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells.
  Shen, J. S., Meng, X. L., Moore, D. F., Quirk, J. M., Shayman, J. A., Schiffmann, R., Kaneski, C. R.> ;Mol Genet Metab. 2008 Nov
• Overlap of mild TBI and mental health conditions in returning OIF/OEF service members and veterans.
  Lew, H. L., Vanderploeg, R. D., Moore, D. F., Schwab, K., Friedman, L., Yesavage, J., Keane, T. M., Warden, D. L., Sigford, B. J.> ;J Rehabil Res Dev. 2008
• Apoptotic abnormalities in differential gene expression in peripheral blood mononuclear cells from children with Fabry disease.
  Moore, D. F., Goldin, E., Gelderman, M. P., Robinson, C., Baer, J., Ries, M., Elkahloun, A., Brady, R. O., Schiffmann, R.> ;Acta Paediatr Suppl. 2008 Apr
• Genomic abnormalities of the murine model of Fabry disease after disease-related perturbation, a systems biology approach.
  Moore, D. F., Gelderman, M. P., Ferreira, P. A., Fuhrmann, S. R., Yi, H., Elkahloun, A., Lix, L. M., Brady, R. O., Schiffmann, R., Goldin, E.> ;Proc Natl Acad Sci U S A. 2007 May 8
• The cerebral vasculopathy of Fabry disease.
  Moore, D. F., Kaneski, C. R., Askari, H., Schiffmann, R.> ;J Neurol Sci. 2007 Jun 15
• Enzyme replacement therapy in orphan and ultra-orphan diseases: the limitations of standard economic metrics as exemplified by Fabry-Anderson disease.
  Moore, D. F., Ries, M., Forget, E. L., Schiffmann, R.> ;Pharmacoeconomics. 2007
• Proteomics of specific treatment-related alterations in Fabry disease: a strategy to identify biological abnormalities.
  Moore, D. F., Krokhin, O. V., Beavis, R. C., Ries, M., Robinson, C., Goldin, E., Brady, R. O., Wilkins, J. A., Schiffmann, R.> ;Proc Natl Acad Sci U S A. 2007 Feb 20
• Fabry disease and vascular risk factors: future strategies for patient-based studies and the knockout murine model.
  Moore, D. F., Gelderman, M. P., Fuhrmann, S. R., Schiffmann, R., Brady, R. O., Goldin, E.> ;Acta Paediatr Suppl. 2006 Apr
• Quantitative dysmorphology assessment in Fabry disease.
  Ries, M., Moore, D. F., Robinson, C. J., Tifft, C. J., Rosenbaum, K. N., Brady, R. O., Schiffmann, R., Krasnewich, D.> ;Genet Med. 2006 Feb
• Effect of genetic modifiers on cerebral lesions in Fabry disease.
  Altarescu, G., Moore, D. F., Schiffmann, R.> ;Neurology. 2005 Jun 28
• Pediatric Fabry disease.
  Ries, M., Gupta, S., Moore, D. F., Sachdev, V., Quirk, J. M., Murray, G. J., Rosing, D. R., Robinson, C., Schaefer, E., Gal, A., Dambrosia, J. M., Garman, S. C., Brady...> ;Pediatrics. 2005 Mar
• Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation.
  Moore, D. F., Li, H., Jeffries, N., Wright, V., Cooper, R. A., Elkahloun, A., Gelderman, M. P., Zudaire, E., Blevins, G., Yu, H., Goldin, E., Baird, A. E.> ;Circulation. 2005 Jan 18
• Join now to see all